文献速递前列腺癌

基于病灶区域与ADC定量值构建临床显著前列腺癌预后预测模型

Development of a Prognostic Prediction Model for Clinically Significant Prostate Cancer Based on Lesion Zone and Apparent Diffusion Coefficient Value Quantification.
PubMed 文献 · Urology · 2026-01-28

本研究基于单中心429名男性546个病灶的mpMRI数据,回顾性分析病灶区域和ADC定量值对临床显著前列腺癌(csPCa)的预测价值。多变量分析显示移行带以外病灶(PZ vs TZ)预测csPCa的OR为2.58(95%CI 1.50-4.44,P<.0005)。联合模型(含区域和PSA密度)AUC为0.78,但模拟场景概率均高于10%的活检省略阈值,未达安全省略活检标准。

要点

  • 病灶区域(PZ vs TZ)是csPCa独立预测因子,OR 2.58。
  • 单独ADC cutoff 700 µm2/s的AUC仅0.56,预测力有限。
  • 联合模型AUC 0.78,但模拟概率16%-82%均高于10%活检省略阈值。

核心结论

  • 前列腺病灶区域和ADC定量值各自独立贡献csPCa预测能力。
  • 模型模拟使用未达到可安全省略活检的阈值。

研究设计与样本

  • 单中心回顾性病灶水平分析,纳入429名男性共546个病灶。
  • mpMRI由专科放射科医生阅片,病理由专科泌尿病理医生分析。

主要发现

  • 多变量分析中,PZ较TZ预测csPCa的OR为2.58(95%CI 1.50-4.44,P<.0005)。
  • 单独ADC cutoff 700 µm2/s的AUC为0.56。
  • 联合模型(含区域和PSA密度)在ADC cutoff 947 µm2/s时AUC为0.78。
  • 模拟场景概率为16%至82%,均高于10%或以下的活检省略阈值。

关键数值与推荐

  • 纳入标准为MRI可见病灶(PI-RADS 3-5)。
  • 活检省略阈值设定为10%或以下。

临床怎么用

  • 病灶区域和ADC定量值可辅助csPCa风险分层。
  • 当前模型尚不能安全用于省略活检决策。

局限性

  • 单中心回顾性设计。
  • 模拟场景概率均高于活检省略阈值,模型临床适用性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To guide biopsy decision making via a predictive model for clinically significant prostate cancer (csPCa) in men with positive imaging (PI-RADS 3-5). We aim to elucidate the influence of zone on the predictive accuracy of PI-RADS v2.1, establish a threshold of quantified apparent diffusion coefficient (ADC) values suspicious for csPCa, and create a logistic-regression model, unique in its inclusion of lesion zone and quantified ADC. METHODS: Data were retrospectively collected from a single cancer center, with institutional review board review and exemption waiver, on a lesion-level retrospective analysis of prostate multiparametric magnetic resonance imaging (mpMRI) of N = 429 men, harboring N = 546 lesions. MRIs were read and reviewed by a fellowship-trained genitourinary/abdominal imaging radiologist. Pathologic analysis was conducted by a fellowship-trained genitourinary pathologist. All statistical analysis including predictive modeling were conducted by an expert biostatistician. RESULTS: On multivariate analysis, zone (PZ as compared to TZ) was a predictor of csPCa (OR 2.58, 95% CI 1.50-4.44, P<.0005). A 700 µm2/s ADC value cutoff in isolation had an AUC of 0.56, but our combined model, bolstered by clinical and imaging data, including zone and prostate-specific antigen density, yielded an AUC of 0.78, at an ADC value cutoff of 947 µm2/s. In application, simulated scenarios yielded probabilities between 16% and 82%, therefore above a biopsy omission threshold of 10% or less. CONCLUSION: Prostate zone and ADC value quantification each independently contribute to csPCa predictability, but no simulated use of the model yielded biopsy-omission thresholds for patients with MRI visible lesions.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Ashouri R, Reynolds PS, Rajavel S, et al. Development of a Prognostic Prediction Model for Clinically Significant Prostate Cancer Based on Lesion Zone and Apparent Diffusion Coefficient Value Quantification. Urology. 2026. PMID: 41616920. doi:10.1016/j.urology.2026.01.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。